Circassia Pharmaceuticals

Products to treat asthma, Chronic Obstructive Pulmonary Disease (COPD) and various allergies.

placeOxford, England, United Kingdom calendar_todayFounded 2006 groups128 employees language circassia.com

Registered entities

Social engagement

Social engagement: 12.3K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Imperial Innovations, Goldman Sachs, Invesco Perpetual.

Investor typeCountShare
Accelerator & incubator114%
Bank & private debt114%
Other / undisclosed571%

Recent activity

2 Jul 2026
Product launch
NIOX PRO®
Coming soon